Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02527018 · ClinicalTrials.gov registry record
A Comparison of BNP Levels Using the Nexfin Device in Healthy Pregnant and Preeclamptic Women
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 66
- Enrollment target
NCT02527018: Completed study, sponsored by University of California, Irvine.
NCT02527018 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 66 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02527018 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 66 participants
- Enrollment target
Study Summary
Primary Endpoint: Quantify the hemodynamic changes in preeclampsia using the non-invasive Nexfin device. Secondary Endpoint: Determine if measurable hemodynamic changes are statistically correlated with B-type natriuretic peptide (BNP) levels.
Primary Outcome
Composite Changes are defined by volume overload (mL), higher B-type natriuretic peptide levels pg/mL, higher blood pressure or cardiac output (mm / Hg).
Interventions
- DEVICE Sphygmomanometer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2014-11 |
| Est. Completion | 2017-10 |
What the finished NCT02527018 record still lists
NCT02527018 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 66 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Sphygmomanometer is the first listed.
NCT02527018 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02527018 about?
NCT02527018 is a clinical study titled "A Comparison of BNP Levels Using the Nexfin Device in Healthy Pregnant and Preeclamptic Women". Primary Endpoint: Quantify the hemodynamic changes in preeclampsia using the non-invasive Nexfin device. Secondary Endpoint: Determine if measurable hemodynamic changes are statistically correlated with B-type natriuretic peptide (BNP) levels.
What is the current status of trial NCT02527018?
This trial is currently completed. The enrollment target is 66 participants. The study started on 2014-11. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02527018?
The interventions under investigation include: Sphygmomanometer (DEVICE).
Who is sponsoring clinical trial NCT02527018?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia